A study on NF1-deficient ER+ breast cancer revealed that NF1 loss drives metabolic reprogramming, leading to impaired oxidative ATP production, increased glutamine flux into the TCA cycle, and an expansion of lipid pools. This evidence concerns the gene NF1 and breast cancer.